Prices delayed by at least 15 minutes | Print


Proteome Sciences PLC (PRM)

ORD 1P
Sell: 3p|Buy: 3.78p|Change: 0.09 (2.73%)

Open 

3.78p


Previous close 

3.3p


Trade high 

3.78p


Volume 

17,740


Year high 

8.79p


Year low 

3.00p


Dividend yield 

-


Market capitalisation 

£10.01 mn


P/E ratio 

15.71


ISIN 

GB0003104196


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Share price

Performance 27/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Proteome Sciences PLC- 5.44
FTSE AIM All Share+ 0.35
More...

Company profile

Proteome Sciences PLC is protein biomarker research and development. The company uses high sensitivity proprietary techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product. Geographically, it has a presence in the United States, the United Kingdom, and the European Union.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
28/03/202402:38:223.12484,426138.30
28/03/202409:27:353.124811,992374.73
28/03/202408:00:083.781,32249.97
27/03/202404:26:033.675,0002,700.00
27/03/202402:40:14310,000300.00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.